Core Viewpoint - The strategic partnership between Baiyang Pharmaceutical and Peking University International Hospital aims to establish a precision radiotherapy center focused on brain tumor treatment, utilizing the ZAP-X robotic system to enhance treatment efficacy and safety for patients [1][2] Group 1: Partnership and Collaboration - Baiyang Pharmaceutical signed a strategic cooperation agreement with Peking University International Hospital to jointly build a precision radiotherapy center [1] - The center will leverage the ZAP-X robotic system, which is recognized as a revolutionary technology in cranial radiotherapy, to improve the precision and safety of brain tumor treatments [1] Group 2: Market Context and Technology - Brain tumors present a global treatment challenge, with traditional surgical methods often leading to secondary injuries such as nerve damage or cerebral edema [1] - The ZAP-X system has been approved for use in 24 countries and regions worldwide, having completed over 5,000 clinical treatments, showcasing its effectiveness in the field [1] Group 3: Future Plans and Vision - Baiyang Pharmaceutical aims to enhance the accessibility of high-quality medical resources and continue the development of the precision radiotherapy center, applying more advanced radiotherapy equipment in clinical settings [2] - The collaboration is seen as a stepping stone for future partnerships in critical areas, with a focus on building a leading medical model that prioritizes technology, service, and patient experience [1]
百洋医药脑肿瘤精准放疗中心签约落地